Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 6

The DOI matches its Crossref record.

Meta-analysis of perioperative outcomes and safety of percutaneous nephrostomy versus retrograde ureteral stenting in the treatment of acute obstructive upper urinary tract infection

Wang, Xidong, Wu, Gang, Wang, Tianqi, Liu, Shangjing, Ding, Guixin, Mao, Qiancheng, Chu, Yongli, Cui, Yuanshan, Wu, Jitao · 2024 · Therapeutic Advances in Urology

Abstract

Background: The debate regarding the optimal drainage method for acute obstructive upper urinary tract infection persists, focusing on the choice between percutaneous nephrostomy (PCN) and retrograde ureteral stenting (RUS). Aims: This study aims to systematically examine the perioperative outcomes and safety associated with PCN and RUS in treating acute obstructive upper urinary tract infections. Methods: A comprehensive investigation was conducted using the Medline, Embase, Web of Science, and Cochrane databases up to December 2022, following the guidelines of the Preferred Reporting Items for Systematic Review and Meta-analysis (PRISMA) statement. The utilized keywords included ‘PCN’, ‘RUS’, ‘acute upper obstructive uropathy’, and ‘RCT’. Inclusion criteria encompassed studies providing accurate and analyzable data, which incorporated the total subject count, perioperative outcomes, and complication rates. The assessed perioperative outcomes included fluoroscopy time, normalization of temperature, normalization of serum creatinine, normalization of white blood cell (WBC) count, and operative time. Safety outcomes encompassed failure rate, intraoperative and postoperative hematuria, postoperative fever, postoperative pain, and postoperative nephrostomy tube or stent slippage rate. The study protocol was prospectively registered at PROSPERO (CRD42022352474). Results: The meta-analysis encompassed 7 trials involving 727 patients, with 412 assigned to the PCN group and 315 to the RUS group. The outcome of the meta-analysis unveiled a reduced occurrence of postoperative hematuria in the PCN group [odds ratio (OR) = 0.54, 95% confidence interval (CI) 0.30–0.99, p = 0.04], along with a decreased frequency of insertion failure (OR = 0.42, 95% CI 0.21–0.81, p = 0.01). In addition, the RUS group exhibited a shorter fluoroscopy time than the PCN group (mean difference = 0.31, 95% CI 0.14–0.48, p = 0.0004). Conclusion: Given the significant impact of hematuria and catheterization failure on postoperative quality of life, the preference for PCN appears more advantageous than RUS.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/17562872241241854

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 35

  1. 10.1016/j.cger.2009.06.003 · DOI
  2. 10.2215/CJN.15341121 · DOI
  3. 10.1111/apa.14482 · DOI
  4. 10.1016/j.cnur.2018.07.007 · DOI
  5. 10.1016/j.juro.2014.07.005 · doi:10.1016/j.juro.2014.07.005
  6. 10.1016/j.jpurol.2021.09.001 · doi:10.1016/j.jpurol.2021.09.001
  7. 10.1097/MOU.0000000000000364 · DOI
  8. 10.21037/tau.2017.10.08 · doi:10.21037/tau.2017.10.08
  9. 10.1016/j.jiac.2018.08.002 · doi:10.1016/j.jiac.2018.08.002
  10. 10.1016/j.ajem.2015.12.068 · DOI
  11. 10.1097/MD.0000000000018519 · DOI
  12. 10.3389/fsurg.2021.718583 · DOI
  13. 10.1016/j.urology.2004.06.029 · doi:10.1016/j.urology.2004.06.029
  14. 10.1007/s00330-005-0136-7 · doi:10.1007/s00330-005-0136-7
  15. 10.1111/iju.14331 · doi:10.1111/iju.14331
  16. 10.1111/bju.12768 · doi:10.1111/bju.12768
  17. 10.1016/S0022-5347(01)62511-4 · DOI · Paper page
  18. 10.14260/jemds/2015/455 · doi:10.14260/jemds/2015/455
  19. 10.1016/j.jiac.2020.11.022 · DOI · Paper page
  20. 10.12669/pjms.293.3563 · doi:10.12669/pjms.293.3563
  21. 10.1016/S0022-5347(05)66434-8 · DOI · Paper page
  22. 10.1016/j.mcna.2017.10.013 · doi:10.1016/j.mcna.2017.10.013
  23. 10.1016/j.juro.2012.09.088 · DOI · Paper page
  24. 10.1016/S0022-5347(17)40763-4 · doi:10.1016/s0022-5347(17)40763-4
  25. 10.1016/j.jvir.2015.11.045 · DOI
  26. 10.1111/bju.12918 · doi:10.1111/bju.12918
  27. 10.1186/s12894-019-0510-4 · DOI · Paper page
  28. 10.4111/icu.2018.59.6.371 · doi:10.4111/icu.2018.59.6.371
  29. 10.1089/end.2020.0867 · doi:10.1089/end.2020.0867
  30. 10.1111/bju.12161 · DOI · Paper page
  31. 10.1038/s41598-021-86136-y · DOI · Paper page
  32. 10.5527/wjn.v5.i2.172 · doi:10.5527/wjn.v5.i2.172
  33. 10.1016/j.euf.2018.09.001 · doi:10.1016/j.euf.2018.09.001
  34. 10.1007/s00240-018-1078-2 · doi:10.1007/s00240-018-1078-2
  35. 10.1016/S1051-0443(94)71470-6 · doi:10.1016/s1051-0443(94)71470-6

Cited by

See all 6

Metadata

Authors
Wang, X., Wu, G., Wang, T., Liu, S., Ding, G., Mao, Q., Chu, Y., Cui, Y., & Wu, J.
Affiliations
  • Department of Urology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, Shandong, China
  • Department of Scientific Research, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, Shandong, China
  • Department of Urology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, Shandong 264000, China
  • Department of Urology, Yantai Yuhuangding Hospital, Qingdao University, No. 20 East Yuhuangding Road, Yantai, Shandong 264000, China
Venue
Therapeutic Advances in Urology
Published
2024-01
Volume
16
ISSN
  • 1756-2872
  • 1756-2880
Cited by
6
References
0
Language
en
Funders
Jitao Wu (National Natural Science Foundation of China, Taishan Scholars Program of Shandong Province)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Meta-analysis of perioperative outcomes and safety of percutaneous nephrostomy versus retrograde ureteral stenting in the treatment of acute obstructive upper urinary tract infection. https://app.cochat.ai/papers/10.1177/17562872241241854
The paper
Wang, X., Wu, G., Wang, T., Liu, S., Ding, G., Mao, Q., Chu, Y., Cui, Y., & Wu, J. (2024). Meta-analysis of perioperative outcomes and safety of percutaneous nephrostomy versus retrograde ureteral stenting in the treatment of acute obstructive upper urinary tract infection. Therapeutic Advances in Urology. https://doi.org/10.1177/17562872241241854

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.